Studies on the controlled release of drugs from magnetic nanobiocomposites

Thomas Heinze, Robert Müller, Mengbo Zhou, Martin Rabel, Paul Warncke, Dagmar FischerIndonesian 2019 · DOI

Abstract

Magnetic nanocomposites are a class of smart materials that have attracted recent interest as drug delivery systems or as medical implants. In this study, meltable nanobiocomposites (NBC) composed of biocompatible dextran fatty acid ester and magnetic nanoparticles (MNPs) melting close to human body temperature were prepared and loaded with Rhodamine B (RhB) or green fluorescent protein (GFP) as model drugs to evaluate their potential use as drug delivery system. The release of the model drugs from the magnetic NBC investigated under the influence of a high frequent alternating magnetic field (AMF, 20 kA/m at 400 kHz) showed that on-demand release is realized applying the external AMF. The NBC showed a long-term stability (28 d) of the incorporated iron oxide particles after incubation in artificial body fluids. This work reveals the potential of the NBC as a drug carrier.

Introduction

The development of drug delivery systems capable of precise spatial and temporal control—releasing therapeutics at specific locations and times—remains a primary goal in biomedical engineering. While magnetic hydrogels have been explored for this purpose, they often face challenges such as drug leakage, poor biocompatibility, or slow response times. Synthetic thermoplastic polymers like PMMA or PLA also present issues regarding biodegradability and immune response. This study investigates a novel approach using dextran, a natural polysaccharide, chemically modified with fatty acids to create a biodegradable, thermoplastic nanobiocomposite (NBC) that melts just above human body temperature (~40–52°C).

Methodology

The researchers synthesized dextran myristate and dextran palmitate "meltable" polymers. These were integrated with oleic acid-coated iron oxide magnetic nanoparticles (MNPs) to ensure hydrophobic compatibility within the polymer matrix. Two model drugs were evaluated to test the system's versatility: Rhodamine B (RhB), a small water-soluble molecule, and Green Fluorescent Protein (GFP), a large protein used to simulate complex biological therapeutics. Drug release was triggered using a high-frequency Alternating Magnetic Field (AMF) at 20 kA/m and 400 kHz. The AMF induces magnetic hyperthermia, causing the MNPs to generate heat, which locally melts the polymer matrix and facilitates drug escape.

Key Insights and Stability

A critical finding was the "shielding effect" provided by the hydrophobic dextran ester matrix. This matrix protected the MNPs from degradation even in acidic environments like Artificial Lysosomal Fluid (ALF, pH 4.5), which typically dissolves iron oxide.

Iron mobilization from the nanobiocomposite in different physiological fluids over time.

Stability tests in Simulated Body Fluid (SBF, pH 7.4) showed less than 0.31% iron release over 28 days, indicating the potential for long-term implantation. Furthermore, the study demonstrated that internal heating via AMF provides a more controlled release mechanism compared to external water bath heating. While external heating melts the surface first, the AMF generates heat from the inside out, providing a more uniform trigger for drugs embedded deep within the matrix.

Results: On-Demand and Pulsatile Release

The NBC system demonstrated successful on-demand triggering, with 12-minute AMF pulses effectively releasing the encapsulated drugs. The release profile was highly dependent on the composite's structure. For instance, "sandwiching" GFP in a dumpling-like structure enabled a sharp, pulsatile "on/off" release with virtually zero leakage during "off" periods.

Pulsatile drug release triggered by alternating magnetic field (AMF) pulses.

While the concept of remote release was proven, the total drug release efficiency was relatively low (e.g., ~16% for RhB over 60 days), suggesting that a significant portion of the drug remains trapped within the polymer core. This indicates that while the "on/off" switch is effective, diffusion through the matrix remains a limiting factor.

Conclusion and Future Directions

This study confirms that dextran-based magnetic nanobiocomposites can serve as effective carriers for controlled, remote-triggered drug release. The system's stability in physiological fluids and its ability to handle both small molecules and large proteins make it a promising candidate for medical implants. Future work will focus on optimizing the geometry of the NBCs, such as creating thinner films or porous structures, to enhance release efficiency and investigating performance in animal models to account for biological factors like blood flow and tissue integration.

Summary updated

Abstract

Magnetic nanocomposites are a class of smart materials that have attracted recent interest as drug delivery systems or as medical implants. In this study, meltable nanobiocomposites (NBC) composed of biocompatible dextran fatty acid ester and magnetic nanoparticles (MNPs) melting close to human body temperature were prepared and loaded with Rhodamine B (RhB) or green fluorescent protein (GFP) as model drugs to evaluate their potential use as drug delivery system. The release of the model drugs from the magnetic NBC investigated under the influence of a high frequent alternating magnetic field (AMF, 20 kA/m at 400 kHz) showed that on-demand release is realized applying the external AMF. The NBC showed a long-term stability (28 d) of the incorporated iron oxide particles after incubation in artificial body fluids. This work reveals the potential of the NBC as a drug carrier.
BibTeX
@inproceedings{heinze2019studies,
  author = {Thomas Heinze and Robert Müller and Mengbo Zhou and Martin Rabel and Paul Warncke and Dagmar Fischer},
  title = {{Studies on the controlled release of drugs from magnetic nanobiocomposites}},
  booktitle = {Indonesian},
  year = {2019},
  doi = {10.24845/ijfac.v4.i1.1},
}
Figure